| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 6093171 | Gastroenterology | 2015 | 41 Pages |
Abstract
Over a median follow-up period of 2.1 years, 28% of patients treated for gastroparesis at centers of expertise had reductions in GCSI scores of 1 or greater, regardless of diabetes. These findings indicate the chronic nature of gastroparesis. We identified factors associated with reduced symptoms that might be used to guide treatment. ClinicalTrials.gov no: NCT00398801.
Keywords
MCIDGPRGERDQOLBDIGCSISF-36v2TPNQuality of lifeSESImprovementgastroesophageal reflux diseaseMinimal Clinically Important DifferenceEtiologybody mass indexBMIGastroparesis Cardinal Symptom IndexPAGI-SYMconfidence intervalodds ratiosocioeconomic statusBDI, Beck Depression InventoryPredictorsTotal parenteral nutrition
Related Topics
Health Sciences
Medicine and Dentistry
Gastroenterology
Authors
Pankaj J. Pasricha, Katherine P. Yates, Linda Nguyen, John Clarke, Thomas L. Abell, Gianrico Farrugia, William L. Hasler, Kenneth L. Koch, William J. Snape, Richard W. McCallum, Irene Sarosiek, James Tonascia, Laura A. Miriel, Linda Lee, Frank Hamilton,